Oxford says vaccine has good immune response with two-dose regime

LONDON (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday. The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result. The details from the Phase I/II clinical trials released on Thursday made no reference to the half-dose/full-dose regime, which Oxford has said had been 'unplanned' but approved by regulators.

Reuters December 18, 2020 00:12:50 IST
Oxford says vaccine has good immune response with two-dose regime

Oxford says vaccine has good immune response with twodose regime

LONDON (Reuters) - Oxford's COVID-19 vaccine candidate has a better immune response when a two full-dose regime is used rather than a full-dose followed by a half-dose booster, the university said on Thursday.

The vaccine candidate, which has been licensed to AstraZeneca, has published interim late stage trial results showing higher efficacy when a half dose is followed by a full dose, compared to a two full-dose regime, though more work needs to be done to affirm the result.

The details from the Phase I/II clinical trials released on Thursday made no reference to the half-dose/full-dose regime, which Oxford has said had been "unplanned" but approved by regulators.

The university said it had explored two dosing regimes in early stage trials, a full-dose/full-dose regime and a full-dose/half-dose regime, investigated as a possible "dose sparing" strategy.

"The booster doses of the vaccine are both shown to induce stronger antibody responses than a single dose, the standard dose/standard dose inducing the best response," the university said in a statement.

The vaccine "stimulates broad antibody and T cell functions," it said after publishing further data from the Phase I/II clinical trials.

(Reporting by Alistair Smout; editing by William James and Mark Heinrich)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Norway imposes new restrictions to prevent new wave, says PM
World

Norway imposes new restrictions to prevent new wave, says PM

OSLO (Reuters) -Norway will impose fresh restrictions to prevent a resurgence in the spread of the coronavirus, Prime Minister Erna Solberg said on Sunday, including a nationwide ban on serving alcohol in restaurants and bars and not inviting guests home.

Indigenous Venezuelan man accused of raiding military post dies in jail: rights group
World

Indigenous Venezuelan man accused of raiding military post dies in jail: rights group

(Reuters) - A Venezuelan member of the Pemon indigenous group accused of aiding a raid on a military post in late 2019 died on Sunday in a jail close to capital Caracas, rights group Penal Forum said in a tweet. Salvador Franco died just weeks after family members and activists reported he was suffering from health problems.

Norway imposes new restrictions to prevent new COVID-19 wave, says PM
World

Norway imposes new restrictions to prevent new COVID-19 wave, says PM

OSLO (Reuters) - Norway will impose fresh restrictions to prevent a resurgence in the spread of the coronavirus, Prime Minister Erna Solberg said on Sunday, including a nationwide ban on serving alcohol in restaurants and bars and not inviting guests home.